Evidence map›Paper›PMID 30735507›Full record

ArticlePloS one2019

Weighted lambda superstrings applied to vaccine design.

Luis Martínez, Martin Milanič, Iker Malaina, Carmen Álvarez, Martín-Blas Pérez, Ildefonso M de la Fuente

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. A Comparison Between RecombinantFrontiers in immunology · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luis MartínezDepartment of Mathematics, University of the Basque Country UPV/EHU, Bilbao, Spain.ORCID 0000-0002-6297-1449
Martin MilaničUniversity of Primorska, UP IAM and UP FAMNIT, Koper, Slovenia.ORCID 0000-0002-8222-8097
Iker MalainaDepartment of Mathematics, University of the Basque Country UPV/EHU, Bilbao, Spain.
Carmen ÁlvarezIDIVAL Valdecilla Biomedical Research Institute, Santander, Spain.
Martín-Blas PérezDepartment of Mathematics, University of the Basque Country UPV/EHU, Bilbao, Spain.
Ildefonso M de la FuenteDepartment of Mathematics, University of the Basque Country UPV/EHU, Bilbao, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We generalize the notion of λ-superstrings, presented in a previous paper, to the notion of weighted λ-superstrings. This generalization entails an important improvement in the applications to vaccine designs, as it allows epitopes to be weighted by their immunogenicities. Motivated by these potential applications of constructing short weighted λ-superstrings to vaccine design, we approach this problem in two ways. First, we formalize the problem as a combinatorial optimization problem (in fact, as two polynomially equivalent problems) and develop an integer programming (IP) formulation for solving it optimally. Second, we describe a model that also takes into account good pairwise alignments of the obtained superstring with the input strings, and present a genetic algorithm that solves the problem approximately. We apply both algorithms to a set of 169 strings corresponding to the Nef protein taken from patiens infected with HIV-1. In the IP-based algorithm, we take the epitopes and the estimation of the immunogenicities from databases of experimental epitopes. In the genetic algorithm we take as candidate epitopes all 9-mers present in the 169 strings and estimate their immunogenicities using a public bioinformatics tool. Finally, we used several bioinformatic tools to evaluate the properties of the candidates generated by our method, which indicated that we can score high immunogenic λ-superstrings that at the same time present similar conformations to the Nef virus proteins.

Indexed as

AIDS VaccinesAlgorithmsEpitopesHIV-1HumansImmunoglobulin lambda-ChainsModels, Theoreticalnef Gene Products, Human Immunodeficiency VirusSequence AlignmentVaccinesAIDS VaccinesEpitopesImmunoglobulin lambda-Chainsnef Gene Products, Human Immunodeficiency VirusVaccines

Identifiers

PMID30735507
PMCPMC6368308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.